Merit Medical Systems | MMSI - Sales Revenues


Merit Medical Systems reported $418.8M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
3M USD 6.5B 500M Jun/2026
Abbott USD 12.59B 1.43B Jun/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Anika Therapeutics USD 30.62M 2.8M Dec/2025
AtriCure USD 153.6M 12.4M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Haemonetics USD 339M 7M Jun/2026
ICU Medical USD 551.68M 25.91M Jun/2026
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
J&J USD 25.4B 89M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Merit Medical Systems USD 418.8M 36.9M Jun/2026
Olympus JPY 240.4B 54.88B Jun/2026
Pfizer USD 15.03B 530M Jun/2026
STAAR Surgical USD 93.5M 0 Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Terumo JPY 311.81B 11.49B Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026